Abstract
Inhibition of oncogenes and reactivation of tumor suppressors are well-established goals in anticancer drug development. Unfortunately many oncogenes and tumor suppressors are not classically druggable, in that they lack a targetable enzymatic activity and associated binding pockets that small molecule drugs can be directed to. This is especially relevant for transcription factors, which have long been thought to be undruggable. To address this gap, we have developed and described CRAFTT, a broadly applicable computational drug-repositioning approach for targeting transcription factors. CRAFTT combines transcription factor target gene sets with drug-induced expression profiling to identify small molecules that can perturb transcription factor activity. Network analysis is then used to derive a modulation index (MI) and prioritize predictions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Libermann TA, Zerbini LF (2006) Targeting transcription factors for cancer gene therapy. Curr Gene Ther 6:17–33
Ablain J, Nasr R, Bazarbachi A, de The H (2011) The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells? Cancer Discov 1:117–127
Delmore JE et al (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904–917
Puissant A et al (2013) Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov 3:308–323
Gayvert KM et al (2016) A computational drug repositioning approach for targeting oncogenic transcription factors. Cell Rep 15:2348–2356
Lamb J et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929–1935
Barrett T, Edgar R (2006) Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol 411:352–369
Giannopoulou EG, Elemento O (2011) An integrated ChIP-seq analysis platform with customizable workflows. BMC Bioinformatics 12:277
Zhang Y et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137
Heinz S et al (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576–589
Szklarczyk D et al (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561–D568
Khurana E, Fu Y, Chen J, Gerstein M (2013) Interpretation of genomic variants using a unified biological network approach. PLoS Comput Biol 9:e1002886
Knox C et al (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39:D1035–D1041
Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760
Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550
Hatzi K et al (2013) A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Cell Rep 4:578–588
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gayvert, K., Elemento, O. (2019). Drug-Induced Expression-Based Computational Repurposing of Small Molecules Affecting Transcription Factor Activity. In: Vanhaelen, Q. (eds) Computational Methods for Drug Repurposing. Methods in Molecular Biology, vol 1903. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8955-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8955-3_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8954-6
Online ISBN: 978-1-4939-8955-3
eBook Packages: Springer Protocols